|
|
Bergen Open Research Archive >
Faculty of Medicine >
Institute of Medicine >
Section for Gastroenterology (Institute of Medicine) >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/1956/1069
|
| Title: | Iron therapy in inflammatory bowel disease : effects on oxidative stress and disease activity |
| Authors: | Erichsen, Kari |
| Issue Date: | 9-Dec-2005 |
| Publisher: | The University of Bergen |
| Description: | This thesis is based on the following papers, referred to in the text by their roman
numerals:
I Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease.
Scand J Gastroenterol 2003;38:543-548. - II Erichsen K, Milde AM, Arslan G, Helgeland L, Gudbrandsen OA, Ulvik RJ,
Berge RK, Hausken T, Berstad A. Low-dose oral ferrous fumarate aggravated
intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis
2005;11:744-748. - III Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T. Oral ferrous fumarate or intravenous iron sucrose for patients
with inflammatory bowel disease. Scand J Gastroenterol 2005;40:1058-1065. - IV Erichsen K, Ulvik RJ, Grimstad T, Berge RK, Berstad A, Hausken T. Effects
of ferrous sulphate and non-ionic iron-polymaltose complex on markers of
oxidative tissue damage in patients with inflammatory bowel disease. Aliment
Pharmacol Ther 2005;22:831-838. |
| URI: | http://hdl.handle.net/1956/1069 |
| ISBN: | 82-308-0071-5 |
| Appears in Collections: | Section for Gastroenterology (Institute of Medicine)
|
Files in This Item:
| File |
Description |
Size | Format |
|---|
| main thesis erichsen.pdf | Main Thesis | 998.78 kB | Adobe PDF | View/Open | | article III.pdf | Reprinted from Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease by Erichsen K, Ulvik RJ, Nysaeter G, Johansen J, Ostborg J, Berstad A, Berge RK, Hausken T, from Scand J Gastroenterol, www.tandf.no/gastro, 2005, 40, 1058-1065, by permission of Taylor & Francis AS | 95.65 kB | Adobe PDF | View/Open | | article I .pdf | Reprinted from Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease by Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK, from Scand J Gastroenterol, www.tandf.no/gastro, 2003, 38, 543-548, by permission of Taylor & Francis AS | 156.44 kB | Adobe PDF | View/Open | | Errata.pdf | | 13.01 kB | Adobe PDF | View/Open | | article IV.pdf | This is an electronic version of an article published in Aliment Pharmacol Ther: ERICHSEN, K., ULVIK, R. J., GRIMSTAD, T., BERSTAD, A., BERGE, R. K. & HAUSKEN, T. (2005) Effects of ferrous sulphate and non-ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 22 (9), 831-838. doi: 10.1111/j.1365-2036.2005.02652.x, as published in the print edition of Aliment Pharmacol Ther, is available on the Blackwell Synergy online delivery service, accessible via the journal's website at http://www.blackwellpublishing.com/journal.asp?ref=0269-2813&site=1 or www.blackwell-synergy.com | 92.31 kB | Adobe PDF | View/Open | | article II.pdf | Erichsen K, Milde AM, Arslan G, Helgeland L, Gudbrandsen OA, Ulvik RJ, Berge RK, Hausken T, Berstad A. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm Bowel Dis 2005;11:744-748 Reprinted with permission from Lippincott Williams & Wilkins. | 726.05 kB | Adobe PDF | View/Open |
|
Items in BORA are protected by copyright, with all rights reserved, unless otherwise indicated.
|
